Literature DB >> 10589019

Allergen avoidance is associated with a fall in exhaled nitric oxide in asthmatic children.

G L Piacentini1, A Bodini, S Costella, L Vicentini, D Peroni, L Zanolla, A L Boner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10589019     DOI： 10.1016/s0091-6749(99)70031-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

1.  Exhaled NO level and number of eosinophils in nasal lavage as markers of pollen-induced upper and lower airway inflammation in children sensitive to grass pollen.

Authors:  J G C van Amsterdam; E W M A Bischoff; A de Klerk; A P J Verlaan; L M N Jongbloets; H van Loveren; A Opperhuizen; G Zomer; M Hady; F T M Spieksma; J A M A Dormans; P A Steerenberg
Journal:  Int Arch Occup Environ Health       Date:  2003-02-26       Impact factor: 3.015

2.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.

Authors:  Raed A Dweik; Peter B Boggs; Serpil C Erzurum; Charles G Irvin; Margaret W Leigh; Jon O Lundberg; Anna-Carin Olin; Alan L Plummer; D Robin Taylor
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

3.  Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial.

Authors:  Robert J Boyle; Christophe Pedroletti; Magnus Wickman; Leif Bjermer; Erkka Valovirta; Ronald Dahl; Andrea Von Berg; Olof Zetterström; John O Warner
Journal:  Thorax       Date:  2011-11-30       Impact factor: 9.139

4.  Outpatient management of asthma in children.

Authors:  André Schultz; Andrew C Martin
Journal:  Clin Med Insights Pediatr       Date:  2013-04-14

5.  House dust mite control measures in the treatment of asthma.

Authors:  Gillian Vallance; Charles McSharry; Stuart Wood; Neil C Thomson
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

6.  Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisons.

Authors:  Uwe Schauer; Karl-Christian Bergmann; Michael Gerstlauer; Sylvia Lehmann; Monika Gappa; Amelie Brenneken; Christian Schulz; Peter Ahrens; Jens Schreiber; Michael Wittmann; Eckard Hamelmann
Journal:  Eur Clin Respir J       Date:  2015-07-29

7.  Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942.

Authors:  Gary Burgess; Malcolm Boyce; Margaret Jones; Lars Larsson; Mark J Main; Frazer Morgan; Peter Phillips; Alison Scrimgeour; Foteini Strimenopoulou; Pavan Vajjah; Miren Zamacona; Roger Palframan
Journal:  EBioMedicine       Date:  2018-08-23       Impact factor: 8.143

8.  Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper.

Authors:  Karin B Fieten; Marieke T Drijver-Messelink; Annalisa Cogo; Denis Charpin; Milena Sokolowska; Ioana Agache; Luís Manuel Taborda-Barata; Ibon Eguiluz-Gracia; Gerrit J Braunstahl; Sven F Seys; Maarten van den Berge; Konrad E Bloch; Silvia Ulrich; Carlos Cardoso-Vigueros; Jasper H Kappen; Anneke Ten Brinke; Markus Koch; Claudia Traidl-Hoffmann; Pedro da Mata; David J Prins; Suzanne G M A Pasmans; Sarah Bendien; Maia Rukhadze; Mohamed H Shamji; Mariana Couto; Hanneke Oude Elberink; Diego G Peroni; Giorgio Piacentini; Els J M Weersink; Matteo Bonini; Lucia H M Rijssenbeek-Nouwens; Cezmi A Akdis
Journal:  Allergy       Date:  2022-02-15       Impact factor: 14.710
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.